Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Understanding and Targeting Metabolism in Erythrocyte Development and Disorders
  • Scientific Program
  • Bookmark Icon
  • Metabolic Switches Underpin Erythropoiesis
  • Schedule
    Notes
  • Location IconMCCNO - 291-292
    Set Timezone
  •  
    Route Me

Generic 'disconnected' Message
Scientific Program




Disclosure:
Agios Pharmaceuticals - Consultancy (Includes expert testimony)

Red
blood cell production is tightly regulated by metabolic pathways that control
differentiation, proliferation, and survival of progenitor cells. Emerging
evidence highlights the pivotal role of metabolic reprogramming in supporting
the energy demands and biosynthetic processes required for red blood cell
maturation. Disruptions in these metabolic pathways can impair erythropoiesis,
contributing to the pathophysiology of red blood cell disorders such as thalassaemia
and myelodysplastic syndromes. Understanding these metabolic programs offers
new therapeutic opportunities. Targeting glucose, purine, pyrimidine, amino
acid, and mitochondrial metabolism, may enhance erythroid differentiation and
improve red blood cell production in disorders with defective erythropoiesis. The
session will kick-off with an introduction of some key metabolic pathways that
are critical for erythropoiesis. Specifically, the session Chair will highlight
how many are expressed at higher levels in red blood cells than in other cell
types due to the action of a few key transcription factors on
erythroid-specific gene promoters and enhancers. 


Dr. Jian Xu will discuss the link between
glutamine metabolism and heme biosynthetic pathways in terminal erythropoiesis.
He will discuss the important role played by glutamine synthetase in
detoxification of haem, and how this is derailed in beta-thalassemia. This new
understanding could pave the way for novel therapies to mitigate ineffective
erythropoiesis.


Dr. Marlies Rossmann will discuss unpublished work on the
interplay between pyrimidine synthesis and ferroptosis in erythropoiesis. Ferroptosis
is an iron-dependent lipid peroxidation process that leads to a unique form of
cell death. It is a prevalent mechanism of ineffective erythropoiesis and red
blood cell destruction in beta-thalassemia. Targeting ferroptosis could be of
therapeutic benefit.


Dr. Lucia De Franceschi will discuss the critical
role played by pyruvate kinase (PK) in red blood cell metabolism. Mature red
blood cells lack mitochondria and thus are heavily dependent upon glycolysis
for generation of ATP for their energy requirements. PK in the final enzyme in
the glycolysis pathway, so red blood cells are particularly sensitive to the
loss of PK enzymatic activity. ATP requirements are also higher when red blood
cells experience oxidative stress, for example in thalassaemia. Dr Franceschi
will summarize extensive clinical trial data of the PK allosteric agonist,
mitapivat, in the treatment of PK deficiency and other red blood cell diseases.
Program
Main Session